After @ months , radius bone mineral density was unchanged in the teriparatide to denosumab group ( @ % -LSB- @ % CI -@ to @ -RSB- ) , whereas it decreased by -@ % ( -@ to @ ) in the denosumab to teriparatide group , and increased by @ % ( @-@ ) in the combination to denosumab group ( p = @ for the teriparatide to denosumab group vs the combination to denosumab group ; p = @ for the denosumab to teriparatide group vs the combination to denosumab group ) .